EUROEYES (01846): Marcus Huascar Bracklo Transferred from Non-Executive Director to Executive Director

Stock News
2025/08/25

EUROEYES (01846) announced that Dr. Markus Braun has tendered his resignation as executive director and chief financial officer of the company due to his personal career development plans. He will also cease to serve as (i) the company's authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the company's authorized representative for receiving legal process documents and notices on behalf of the company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from September 14, 2025.

Mr. Marcus Huascar Bracklo has been transferred from non-executive director to executive director and appointed as chief financial officer, effective from September 14, 2025.

Effective from September 14, 2025: (a) Mr. Bracklo will no longer serve as a member of the audit committee; (b) Ms. Katherine Rong Xin, an independent non-executive director, will be appointed as a member of the audit committee; and (c) the audit committee will comprise Mr. Philip Duncan Wright (chairman), Mr. Hans Helmuth Hennig, and Ms. Xin.

Following his appointment and effective from September 14, 2025, Mr. Bracklo has been appointed as the authorized representative under the Listing Rules and the authorized representative and agent for service of process under the Companies Ordinance, filling the vacancy left by Dr. Braun.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10